Now playing Next Health news Moderna sues Pfizer-BioNTech for copying tech behind COVID vaccines Moderna is suing its biggest rivals over claims they stole "groundbreaking technology" used in mRNA vaccines. 26/08/2022
Now playing Next Health news Britain approves Moderna's Omicron-adapted COVID booster Each dose of the booster shot will target both the original COVID virus that was first detected in 2020 and the omicron BA.1 variant. 15/08/2022
Now playing Next Europe News EU secures 15 million more doses of Moderna's adapted COVID vaccine The European Commission secured an additional 15 million doses of vaccine boosters from Moderna adapted for the Omicron variant. 09/08/2022
Now playing Next Health news Which countries are using monkeypox vaccines? The number of monkeypox cases in Western countries is growing. Here’s a list of which nations are buying vaccines. 27/05/2022
Now playing Next Health news How do you get a reluctant Briton, German or Italian vaccinated? Protection against COVID-19, the right to eat out or to travel abroad: a study looked into what might sway vaccine-hesitant adults across eight European countries. 06/05/2022
Now playing Next Travel News Do you count as vaccinated in these top European holiday destinations? Minor differences in what counts as vaccinated can lead to major problems when you arrive at the border. 26/04/2022
Now playing Next Health news Valneva’s inactivated COVID vaccine gets first approval in UK Valneva’s COVID-19 vaccine uses traditional technology that may appeal to people reluctant to take mRNA shots. 14/04/2022
Now playing Next Health news Too early to consider 4th COVID vaccine dose, say EU medical bodies While most people won't be considered for a fourth dose of COVID mRNA vaccine, those over 80 will be encouraged to get a second booster. 06/04/2022
Now playing Next Health news Subvariant BA.2: What we know about the most dominant COVID strain BA.2, one of three known subvariants of Omicron, is now the most dominant form of COVID in the world, believed to be more transmissible than previous strains. 30/03/2022
Now playing Next Health news Moderna seeks emergency approval for COVID vaccine in kids under 6 Moderna’s COVID vaccine is around 44 per cent effective for children aged 6 months to 2 years old, early clinical trial results show. 23/03/2022
Now playing Next Health news 1 in 4 symptomatic children hit by long COVID, says new study Data from more than 80,000 children with COVID suggests a quarter of them had symptoms that lingered for at least 4-12 weeks. 15/03/2022
Now playing Next Health news Moderna COVID vaccine approved by EU regulator for children aged 5-11 The European Medicines Agency also recommended booster shots for children aged 12 and older. 03/03/2022
Now playing Next Health news COVID vaccines for children: How do European countries compare? The EMA authorised the use of the Pfizer vaccine for children over 5 years-old and the Omicron variant has put a renewed focus on countries' vaccination campaigns. Which European countries are now vaccinating young people? 25/02/2022
Now playing Next world news EU resists calls for IP waivers but agrees to transfer mRNA technology The European Commission, Germany, France and Belgium will invest €40 million to help six African countries produce mRNA vaccines at scale. 18/02/2022
Now playing Next Health news Pfizer/BioNTech to start clinical trials on new Omicron COVID vaccine A new formulation of the COVID-19 jab based on the highly infectious Omicron variant is now in clinical trials, the drugmakers said on Tuesday 25/01/2022
Now playing Next USA Booster shots needed against Omicron, US CDC studies show Three studies released on Friday offered more evidence that COVID-19 vaccines are standing up to the Omicron variant, at least among people who received booster shots. 21/01/2022
Now playing Next Health news Get ready for yearly COVID-flu combo vaccines, say Moderna and Pfizer Vaccine maker Moderna predicted that its seasonal COVID and flu boosters would be available in some countries within the next two years. 18/01/2022